Navigation Links
SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern
Date:7/29/2008

BELLEVUE, Wash., July 29 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD) today announced plans to release second quarter 2008 financial results on Thursday, August 7, 2008, at 8:30 a.m. Eastern. Daniel O. Wilds, President and CEO of SCOLR Pharma, will host a conference call at 11:30 a.m. Eastern, to discuss the results.

Shareholders and other interested parties may participate in the conference call by dialing +1 888 680 0878 (domestic) or +1 617 213 4855 (international) and entering access code 26733631, a few minutes before 11:30 a.m. ET on August 7, 2008. The call will also be broadcast live on the Internet at http://www.streetevents.com, http://www.fulldisclosure.com or http://www.scolr.com.

A replay of the conference call will be accessible two hours after its completion through August 21, 2008, by dialing +1 888 286 8010 (domestic) or +1 617 801 6888 (international) and entering access code 55141034. The call will also be archived for 90 days at http://www.streetevents.com, http://www.fulldisclosure.com or http://www.scolr.com.

Based in Bellevue, Washington, SCOLR Pharma, Inc. is a specialty pharmaceutical company. SCOLR Pharma's corporate objective is to combine its formulation expertise and its patented CDT platform to develop novel pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platform is based on multiple issued and pending patents and oth
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
2. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
3. China Biopharma, Inc. Announces New Plan of Operation
4. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
5. GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
6. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
7. Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today
8. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
9. Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings
10. Schering-Plough Schedules Webcast for Annual Meeting of Shareholders
11. ImaRx Schedules Release of First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... Ambit Biosciences Corporation announced today the enrollment and dosing ... Center of the first patient in the ACE ( ... fficacy) Phase 2 pivotal trial in patients with relapsed ... a novel, orally available, potent and highly selective small ... kinase-3 (FLT3) inhibitor. The ACE study is designed ...
(Date:12/11/2009)... Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or ... Alan Warrander to the role of Senior Vice ... Warrander will be responsible for the execution of ... Brad Thompson, President and CEO of Oncolytics. "Having ... Phase 3 trial examining REOLYSIN in combination with ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... 1 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology,International, Inc. (OTC Bulletin ... of nutrients for plants and animals, located in ... named Mr. Sam Yu to be the,Company,s new ... Mr. Yu,replaces Larry Gilmore, who served as the ...
... YORK, England and BETHESDA, Md., April 1,/PRNewswire-Asia/ -- ... the client-service standard with its inherently flexible,approach, and ... today announced a,partnership to provide central lab services ... UFH is a CAP-certified facility owned by Chindex,International, ...
... State University are developing a technique for mass producing ... pencils. , Experts believe that graphene -- the sheet-like ... the key to smaller, faster electronics. It might also ... of electronics. , Until now, most researchers could only ...
Other Biology Technology:Yongye Biotechnology Appoints New Chief Financial Officer 2Yongye Biotechnology Appoints New Chief Financial Officer 3ACM Global Central Lab Announces Partnership with Chindex's United Family Hospitals in China 2ACM Global Central Lab Announces Partnership with Chindex's United Family Hospitals in China 3ACM Global Central Lab Announces Partnership with Chindex's United Family Hospitals in China 4Researchers find better way to manufacture fast computer chips 2Researchers find better way to manufacture fast computer chips 3
(Date:12/11/2009)... increases, growers are being challenged to bring consistently ... bottom line, orchard owners are experimenting with new ... labor costs. , Hand thinning, a common practice ... is among the most labor-intensive of orchard practices, ... and, ultimately, prices paid by consumers. A research ...
(Date:12/11/2009)... stress collectively weigh and initiate different survival strategies say ... strategic decisions that affect their health, wealth and the ... this week in the early online edition of the ... , was accomplished when the scientists applied the mathematical ... of genes and proteins that colonies of bacteria rely ...
(Date:12/11/2009)... decades, Ivy Pike, an associate professor of anthropology at ... in rural northern Kenya to understand how violence shapes ... , The results of her and her colleagues, research," ... pastoralist communities of northern Kenya: A conceptual framework," is ... Science and Medicine , in collaboration with the British ...
Breaking Biology News(10 mins):Horizontal string trimmer reduces labor costs, increases peach size 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food 26 Beverage and Dietary Supplements Sector Reve 13186 1Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food 26 Beverage and Dietary Supplements Sector Reve 13186 2Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food 26 Beverage and Dietary Supplements Sector Reve 13186 3Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food 26 Beverage and Dietary Supplements Sector Reve 13186 4Time Clocks Technology Catches Up With Crooks 13183 1Time Clocks Technology Catches Up With Crooks 13183 2Time Clocks Technology Catches Up With Crooks 13183 3Cell Therapeutics Inc Announces Exercise of Overallotment 13182 1Cell Therapeutics Inc Announces Exercise of Overallotment 13182 2Cell Therapeutics Inc Announces Exercise of Overallotment 13182 3
... cell can turn into bone, muscle, neurons or other types ... according to researchers at the University of Pennsylvania. ... reside in the bone marrow as part of the body's ... environment in order to transform into different types of tissue. ...
... of human subjects to operate a robot-controlled joystick, Johns Hopkins ... control certain muscle movements, the more likely it is to ... investigators say, could alter rehabilitation approaches for people who have ... In a report on the work in the May 23 ...
... researchers have found a group of cells in the ... on T-cells, cells that help fight infection. , The ... of the journal Immunity, released today. , "This connection ... help in studying and developing treatments for diseases that ...
Other Biology News:Adult stem cells are touchy-feely, need environmental clues 2New approach to vaccine development provides potent, long-lasting immunity 2New approach to vaccine development provides potent, long-lasting immunity 3